Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Cash Flow Reinvestment Rate
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Cash Flow Reinvestment Rate of 7.86x as of December 2025, reinvesting CN¥176.01 Million (capex CN¥7.07 Million plus investments CN¥-168.93 Million) from operating cash flow of CN¥22.41 Million. Explore Shanghai Rendu Biotechnology Co. Ltd. A capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. Also explore Shanghai Rendu Biotechnology Co. Ltd. A balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year capital reinvestment analysis for Shanghai Rendu Biotechnology Co. Ltd. A. For live market cap and broader valuation context, see market cap of Shanghai Rendu Biotechnology Co. Ltd. A.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.86x | CN¥176.01 Million | CN¥22.41 Million | CN¥7.07 Million | ▼ -40.7% |
| 2024 | 13.25x | CN¥323.10 Million | CN¥24.39 Million | CN¥10.52 Million | ▼ -33.5% |
| 2023 | 19.91x | CN¥342.31 Million | CN¥17.19 Million | CN¥20.39 Million | ▲ +2071.2% |
| 2021 | 0.92x | CN¥49.93 Million | CN¥54.44 Million | CN¥26.48 Million | ▲ +145.3% |
| 2020 | 0.37x | CN¥34.62 Million | CN¥92.61 Million | CN¥15.55 Million | ▼ -92.0% |
| 2019 | 4.66x | CN¥63.70 Million | CN¥13.67 Million | CN¥54.83 Million | — |